Evoke Pharma, Inc.(NASDAQ : EVOK)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Other
|SAVA||Cassava Sciences, Inc.||19.32%||82.97||0.0%||$464.09m|
|VRX||Valeant Pharmaceuticals International, Inc.||1.27%||29.62||14.1%||$174.29m|
|HZNP||Horizon Therapeutics Plc||-0.94%||99.08||5.5%||$111.71m|
|JAZZ||Jazz Pharmaceuticals Plc||0.64%||170.60||2.2%||$84.73m|
|PRGO||Perrigo Co. Plc||1.03%||48.53||6.9%||$49.39m|
|ENDP||Endo International Plc||-0.39%||5.04||8.6%||$45.85m|
|BHC||Bausch Health Cos., Inc.||1.27%||29.62||0.0%||$43.06m|
|UTHR||United Therapeutics Corp.||-0.47%||181.07||14.0%||$39.17m|
|SAGE||SAGE Therapeutics, Inc.||1.02%||44.18||7.6%||$32.64m|
|NTEC||Intec Pharma Ltd.||-1.65%||11.10||0.0%||$31.03m|
|IRWD||Ironwood Pharmaceuticals, Inc.||0.60%||13.35||9.6%||$25.47m|
|AXSM||Axsome Therapeutics, Inc.||4.24%||50.65||1.9%||$17.99m|
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.